Concepedia

Srinivas Adurthi

SA

Statistics

Publications

3

Citations

218

H-Index

3

Active since

2012

Affiliations

Aurigene Discovery Technologies (India)(Current)

Srinivas Adurthi is an author at Aurigene Discovery Technologies (India) specializing in t cell immunity, immune regulation, and cancer research.

Top concepts

Publications per year

2012–2021

3

Publications

3

PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy

Pottayil G. Sasikumar, Naremaddepalli S. Sudarshan, Srinivas Adurthi et al. · Communications Biology · 2021 · 144 citations · Full text

A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy

Pottayil G. Sasikumar, Raghuveer Ramachandra, Srinivas Adurthi et al. · Molecular Cancer Therapeutics · 2019 · 61 citations · Full text

Abstract 2850: Demonstration of anti-tumor efficacy in multiple preclinical cancer models using a novel peptide inhibitor (Aurigene-012) of the PD1 signaling pathway

Pottayil G. Sasikumar, Leena K. Satyam, Rajeev Shrimali et al. · Cancer Research · 2012 · 13 citations

, , +26

1–3 of 3